242 related articles for article (PubMed ID: 20068137)
1. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G
Diabetes; 2010 Apr; 59(4):1046-54. PubMed ID: 20068137
[TBL] [Abstract][Full Text] [Related]
2. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
3. Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.
Barutta F; Bellini S; Mastrocola R; Gambino R; Piscitelli F; di Marzo V; Corbetta B; Vemuri VK; Makriyannis A; Annaratone L; Bruno G; Gruden G
Br J Pharmacol; 2018 Dec; 175(23):4371-4385. PubMed ID: 30184259
[TBL] [Abstract][Full Text] [Related]
4. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
[TBL] [Abstract][Full Text] [Related]
5. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
6. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
[TBL] [Abstract][Full Text] [Related]
8. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
9. A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes.
Zhang J; Gu C; Lawrence DA; Cheung AK; Huang Y
Exp Physiol; 2014 May; 99(5):802-15. PubMed ID: 24443353
[TBL] [Abstract][Full Text] [Related]
10. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
[TBL] [Abstract][Full Text] [Related]
11. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.
Xiao T; Guan X; Nie L; Wang S; Sun L; He T; Huang Y; Zhang J; Yang K; Wang J; Zhao J
Mol Cell Biochem; 2014 Sep; 394(1-2):145-54. PubMed ID: 24850187
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
Irwin N; Hunter K; Frizzell N; Flatt PR
Eur J Pharmacol; 2008 Feb; 581(1-2):226-33. PubMed ID: 18191122
[TBL] [Abstract][Full Text] [Related]
16. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
17. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
18. [Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism].
Liu G; Guan GJ; Qi TG; Fu YQ; Li XG; Sun Y; Wu T; Wen RZ
Zhong Xi Yi Jie He Xue Bao; 2005 Nov; 3(6):459-62. PubMed ID: 16282056
[TBL] [Abstract][Full Text] [Related]
19. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
